AAAAAA

   
Results: 1-10 |
Results: 10
APOPTOTIC CELL-DEATH, DETECTED EX-VIVO IN PERIPHERAL-BLOOD LYMPHOCYTES OF HIV-1-INFECTED PERSONS
Authors: VELDE LFT VERMES I HAANEN C REUTELINGSPERGER CPM TENNAPEL CHH
Citation: Lft. Velde et al., APOPTOTIC CELL-DEATH, DETECTED EX-VIVO IN PERIPHERAL-BLOOD LYMPHOCYTES OF HIV-1-INFECTED PERSONS, Mediators of inflammation, 5(5), 1996, pp. 379-381
TREATMENT OF THE BUDD-CHIARI SYNDROME BY INSERTION OF A WALL-STENT INTHE HEPATIC VEIN AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY - THE NECESSITY OF FOLLOW-UP
Authors: WEERNINK EEM HUISMAN AB VANBAARLEN J TENNAPEL CHH
Citation: Eem. Weernink et al., TREATMENT OF THE BUDD-CHIARI SYNDROME BY INSERTION OF A WALL-STENT INTHE HEPATIC VEIN AFTER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY - THE NECESSITY OF FOLLOW-UP, European journal of gastroenterology & hepatology, 8(1), 1996, pp. 85-88
TREATMENT OF POOR-PROGNOSIS EPIDEMIC KAPOSIS-SARCOMA WITH DOXORUBICIN, BLEOMYCIN, VINDESINE AND RECOMBINANT HUMAN GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR (RH GM-CSF)
Authors: BAKKER PJM DANNER SA TENNAPEL CHH KROON FP SPRENGER HG VANLEUSEN R MEENHORST PL MUUSERS A VEENHOF CHN
Citation: Pjm. Bakker et al., TREATMENT OF POOR-PROGNOSIS EPIDEMIC KAPOSIS-SARCOMA WITH DOXORUBICIN, BLEOMYCIN, VINDESINE AND RECOMBINANT HUMAN GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR (RH GM-CSF), European journal of cancer, 31A(2), 1995, pp. 188-192
LIMITED SAMPLING MODELS FOR THE ANTIRETROVIRAL AGENT DIDANOSINE
Authors: BURGER DM MEENHORST PL TENNAPEL CHH MULDER JW HENRICHS JH FRISSEN PHJ KROON FP KOKS CHW BULT A BEIJNEN JH
Citation: Dm. Burger et al., LIMITED SAMPLING MODELS FOR THE ANTIRETROVIRAL AGENT DIDANOSINE, European journal of pharmaceutical sciences, 3(1), 1995, pp. 7-13
ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/
Authors: FERNANDEZCRUZ E LANG JM FRISSEN J FURNER V CHATEAUVERT M BOUCHER CAB DOWD P STEVENS J GOLD J MICHELMORE H BENSON E SPELMAN E HOY J WRIGHT E FRENCH M HUDSON J MALLAL S BODSWORTH N STINGL G MAYERHOFER S KRONAWETTER M TSOUKAS C SZABO T KATLAMA C GUERMONPREZ G RAFFI F BILLAUD E MILPIED B BOURGEOT V FLEISHMANN M BARRIER JH DELZANT G WINTER C MEHARZI J TREPO C COTTE L ROUGIER P HASSAIRI N CHOUTET P BESNIER JM LAFEUILLADE A RASOKAT H GROSS G MAUSCH HE STRATIGOS J POLYDOROV D STAVRIANEAS N KIOSSES V MANDALAKI T KARAFOULIDOU A KARABINIS A STERGIOU G PLOUMIDES G PITSAS A TASSOPOULOS N KOUTSOUNOPOULOS G HATZAKIS A MORONI M DARMINIO A BINI T CHIODO F COLANGELI V RICCHI E AIUTI F FERRARA R MEZZAROMA I LANGE JMA FRISSEN PHJ SPRENGER HG KROON FP VANDERENDE ME DEMARIE S KOOPMANS PP DOLMANS WMV SCHREIJ GS WEIGEL HM TENNAPEL CHH TENKATE RW MARANON G ZABAY JM COSIN J PENA JM RUBIO R RIBERA E VAZQUEZ JMM LEAL M ANDREU J CARTON JA ASENSI V GOMEZTRUJILLO F ORIHUELA F SERRANO C FERRER E MANDAL BK JOHNSON M MCKARTHY K FARMER D TANG A MITCHELL SA BROWN J TOORAWA R YEO J
Citation: E. Fernandezcruz et al., ZIDOVUDINE PLUS INTERFERON-ALPHA VERSUS ZIDOVUDINE ALONE IN HIV-INFECTED SYMPTOMATIC OR ASYMPTOMATIC PERSONS WITH CD4-THAN-150X10(6)( CELL COUNTS GREATER)I - RESULTS OF THE ZIDON TRIAL/, AIDS, 9(9), 1995, pp. 1025-1035
EFFICACY AND TOXICITY OF 2 DOSES OF TRIMETHOPRIM-SULFAMETHOXAZOLE AS PRIMARY PROPHYLAXIS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTSWITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: SCHNEIDER MME NIELSEN TL NELSING S HOEPELMAN AIM SCHATTENKERK JKME VANDERGRAAF Y KOLSTERS AFP BORLEFFS JCC DANNER SA VANLEEUWEN R FRISSEN JPHJ WEIGEL HM VANDERENDE IME SPRENGER HG KAUFFMANN RH KROON F MEENHORST PL TENNAPEL CHH SCHREIJ G TENKATE RW JUTTMANN JR KOOPMANS PP
Citation: Mme. Schneider et al., EFFICACY AND TOXICITY OF 2 DOSES OF TRIMETHOPRIM-SULFAMETHOXAZOLE AS PRIMARY PROPHYLAXIS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTSWITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of infectious diseases, 171(6), 1995, pp. 1632-1636
PHARMACOKINETIC VARIABILITY OF ZIDOVUDINE IN HIV-INFECTED INDIVIDUALS- SUBGROUP ANALYSIS AND DRUG-INTERACTIONS
Authors: BURGER DM MEENHORST PL TENNAPEL CHH MULDER JW NEEF C KOKS CHW BULT A BEIJNEN JH
Citation: Dm. Burger et al., PHARMACOKINETIC VARIABILITY OF ZIDOVUDINE IN HIV-INFECTED INDIVIDUALS- SUBGROUP ANALYSIS AND DRUG-INTERACTIONS, AIDS, 8(12), 1994, pp. 1683-1689
APPLICATION OF A RADIOIMMUNOASSAY FOR DETERMINATION OF LEVELS OF ZALCITABINE (DDC) IN HUMAN PLASMA, URINE, AND CEREBROSPINAL-FLUID
Authors: BURGER DM ROSING H TENNAPEL CHH DUYTS T MEENHORST PL MULDER JW KOKS CHW BULT A BEIJNEN JH
Citation: Dm. Burger et al., APPLICATION OF A RADIOIMMUNOASSAY FOR DETERMINATION OF LEVELS OF ZALCITABINE (DDC) IN HUMAN PLASMA, URINE, AND CEREBROSPINAL-FLUID, Antimicrobial agents and chemotherapy, 38(12), 1994, pp. 2763-2767
ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: FRISSEN PHJ VANDERENDE ME TENNAPEL CHH WEIGEL HM SCHREIJ GS KAUFFMANN RH KOOPMANS PP HOEPELMAN AIM DEBOER JB WEVERLING GJ HAVERKAMP G DOWD P MIEDEMA F SCHUURMAN R BOUCHER CAB LANGE JMA
Citation: Phj. Frissen et al., ZIDOVUDINE AND INTERFERON-ALPHA, COMBINATION THERAPY VERSUS ZIDOVUDINE MONOTHERAPY IN SUBJECTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 169(6), 1994, pp. 1351-1355
THE CONCORDE TRIAL
Authors: DANNER SA SCHATTENKERK JKME LOELIGER AE VANDERMEER JTM REISS P HENRICHS JM FRISSEN PHJ WEIGEL HM MULDER JW MEENHORST PL VANDERWOLF MGB TENVEEN JH CLAESSEN FAP VEENSTRA J BORLEFFS JCC HOEPELMAN IM SCHNEIDER ME DEMARIE S VANDERENDE ME VOETS W KAUFFMANN RH KROON FP JUTTMAN JR FOLMER SCCR FERWERDA J TENKATE RW VANLEUSEN R VREDEN SGS PERENBOOM R SPRENGER HG TENNAPEL CHH
Citation: Sa. Danner et al., THE CONCORDE TRIAL, Lancet, 341(8855), 1993, pp. 1276-1276
Risultati: 1-10 |